World Health Organization. World obesity day 2022. WHO. Accessed Jun 11, 2023. https://www.who.int/news/item/04-03-2022-world-obesity-day-2022-accelerating-action-to-stop-obesity.

Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, Anderson EJ, Weigel A, Monroe ML, Reeg L, Bye E, Sosin DM, Muse A, Bennett NM, Billing LM, Sutton M, Talbot HK, McCaffrey K, Pham H, Patel K, Whitaker M, L McMorrow M, P Havers F. Risk factors for severe COVID-19 in children. Pediatrics. 2022;149(1):e2021053418. https://doi.org/10.1542/peds.2021-053418. Epub 2021 Dec 22. PMID: 34935038; PMCID: PMC9213563.

Ward ZJ, Long MW, Resch SC, Giles CM, Cradock AL, Gortmaker SL. Simulation of growth trajectories of childhood obesity into adulthood. N Engl J Med. 2017;377(22):2145–53. https://doi.org/10.1056/NEJMoa1703860. PMID: 29171811; PMCID: PMC9036858.

Article  PubMed  PubMed Central  Google Scholar 

Gudzune KA, Johnson VR, Bramante CT, Stanford FC. Geographic availability of physicians certified by the American Board of Obesity Medicine relative to obesity prevalence. Obesity (Silver Spring). 2019;27(12):1958–1966. https://doi.org/10.1002/oby.22628. Epub 2019 Sep 13. PMID: 31515965; PMCID: PMC6868336.

Kaye AD, Okeagu CN, Pham AD, Silva RA, Hurley JJ, Arron BL, Sarfraz N, Lee HN, Ghali GE, Gamble JW, Liu H, Urman RD, Cornett EM. Economic impact of COVID-19 pandemic on healthcare facilities and systems: international perspectives. Best Pract Res Clin Anaesthesiol. 2021;35(3):293–306. https://doi.org/10.1016/j.bpa.2020.11.009. Epub 2020 Nov 17. PMID: 34511220; PMCID: PMC7670225.

• Cuda S, Censani M, Kharofa R, O'Hara V, Conroy R, Williams D, Paisley J, Browne A, Karjoo S, Browne NT. Medication-induced weight gain and advanced therapies for the child with overweight and obesity: an Obesity Medicine Association (OMA) Clinical Practice Statement 2022, Obesity Pillars. 2022;4:100048, ISSN 2667–3681. https://doi.org/10.1016/j.obpill.2022.100048. Provides comprehensive review of advanced treatment for pediatric obesity.

O’Hara V, Cuda S, Kharofa R, Censani M, Conroy R, Browne NT. Clinical review: guide to pharmacological management in pediatric obesity medicine. Obesity Pillars. 2023;6:100066, ISSN 2667–3681. https://doi.org/10.1016/j.obpill.2023.100066.

Flattum C, Friend S, Horning M, Lindberg R, Beaudette J, Fulkerson JA. Family-focused obesity prevention program implementation in urban versus rural communities: a case study. BMC Public Health. 2021;21(1):1915. https://doi.org/10.1186/s12889-021-11967-3. PMID: 34674674; PMCID: PMC8532281.

Article  PubMed  PubMed Central  Google Scholar 

SanGiovanni C, McElligott J, Morella K, Basco W Jr. Underdiagnosis and lower rates of office visits for overweight/obese pediatric patients in rural compared with urban areas. South Med J. 2017;110(7):480–5. https://doi.org/10.14423/SMJ.0000000000000672. PMID: 28679018.

Article  PubMed  Google Scholar 

Strochlic R, Au LE, Ritchie L. Is urban-rural location associated with weight status in school children? An examination of 42 small and rural Californian counties. Rural Remote Health. 2017;17(2):3966. https://doi.org/10.22605/RRH3966. Epub 2017 Apr 18. PMID: 28415846.

Ogden CL, Fryar CD, Hales CM, Carroll MD, Aoki Y, Freedman DS. Differences in obesity prevalence by demographics and urbanization in US children and adolescents, 2013–2016. JAMA. 2018;319(23):2410–8. https://doi.org/10.1001/jama.2018.5158. PMID: 29922826; PMCID: PMC6393914 .

Article  PubMed  PubMed Central  Google Scholar 

Srivastava G, Browne N, Kyle TK, O’Hara V, Browne A, Nelson T, Puhl R. Caring for US children: barriers to effective treatment in children with the disease of obesity. Obesity (Silver Spring). 2021;29(1):46–55. https://doi.org/10.1002/oby.22987. PMID: 34494365.

Article  PubMed  Google Scholar 

Halford JCG, Bereket A, Bin-Abbas B, Chen W, Fernández-Aranda F, Garibay Nieto N, López Siguero JP, Maffeis C, Mooney V, Osorto CK, Reynoso R, Rhie YJ, Toro-Ramos M, Baur LA. Misalignment among adolescents living with obesity, caregivers, and healthcare professionals: ACTION Teens global survey study. Pediatr Obes. 2022;17(11):e12957. https://doi.org/10.1111/ijpo.12957. Epub 2022 Jul 15. PMID: 35838551.

• Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, Lunsford D, Mendonca E, Michalsky MP, Mirza N, Ochoa ER, Sharifi M, Staiano AE, Weedn AE, Flinn SK, Lindros J, Okechukwu K. Clinical Practice Guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151(2):e2022060640. https://doi.org/10.1542/peds.2022-060640. Important first AAP CPG since 2007 highlighting the need to treat obesity as a chronic disease using all available therapies.

Article  PubMed  Google Scholar 

Di Cesare M, Sorić M, Bovet P, Miranda JJ, Bhutta Z, Stevens GA, Laxmaiah A, Kengne AP, Bentham J. The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med. 2019;17(1):212. https://doi.org/10.1186/s12916-019-1449-8. PMID: 31760948; PMCID: PMC6876113.

Article  PubMed  PubMed Central  Google Scholar 

Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022–4180 Trial Investigators. A randomized, controlled trial of Liraglutide for adolescents with obesity. N Engl J Med. 2020;382(22):2117–2128. https://doi.org/10.1056/NEJMoa1916038. Epub 2020 Mar 31. PMID: 32233338.

Kelly AS, Bensignor MO, Hsia DS, Shoemaker AH, Shih W, Peterson C, Varghese ST. Phentermine/topiramate for the treatment of adolescent obesity. NEJM Evid. 2022. https://doi.org/10.1056/evidoa2200014. Epub 2022 Apr 30. PMID: 36968652; PMCID: PMC10035585.

Weghuber D, Barrett T, Barrientos-Pérez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Sørrig R, Arslanian S; STEP TEENS Investigators. Once-weekly semaglutide in adolescents with obesity. N Engl J Med. 2022;387(24):2245–2257. https://doi.org/10.1056/NEJMoa2208601. Epub 2022 Nov 2. PMID: 36322838; PMCID: PMC9997064.

Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, Kohlsdorf K, Poitou C, Puder L, Swain J, Stewart M, Yuan G, Wabitsch M, Kühnen P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diab Endocrinol. 2020;8(12):960–970. https://doi.org/10.1016/S2213-8587(20)30364-8. Epub 2020 Oct 30. PMID: 33137293.

Cuda S, Censani M. Progress in pediatric obesity: new and advanced therapies. Curr Opin Pediatr. 2022;34(4):407–13. https://doi.org/10.1097/MOP.0000000000001150. Epub 2022 Jul 5 PMID: 35797460.

Article  CAS  PubMed  Google Scholar 

Lazareva J, Brady SM, Yanovski JA. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet-Biedl syndrome. Expert Opin Pharmacother. 2023;24(6):667–674. https://doi.org/10.1080/14656566.2023.2199152. Epub 2023 Apr 6. PMID: 37013719; PMCID: PMC10121918.

Gross AC, Kaizer AM, Kelly AS, Rudser KD, Ryder JR, Borzutzky CR, Santos M, Tucker JM, Yee JK, Fox CK; POWER Work Group. Long and short of it: early response predicts longer-term outcomes in pediatric weight management. Obesity (Silver Spring). 2019;27(2):272–279. https://doi.org/10.1002/oby.22367. PMID: 30677263; PMCID: PMC6352906.

Herdes RE, Tsao DD, Pratt JSA. Why earlier may be better: a look at the use of metabolic and bariatric surgery in the treatment of severe childhood obesity. Surg Obes Relat Dis. 2021;17(12):2107–10. https://doi.org/10.1016/j.soard.2021.09.003. (Epub 2021 Sep 8 PMID: 34565685).

Article  PubMed  Google Scholar 

Borzutzky C, King E, Fox CK, Stratbucker W, Tucker J, Yee JK, Kumar S, Cuda S, Sweeney B, Kirk S, On Behalf Of The Power Work Group. Trends in prescribing anti-obesity pharmacotherapy for paediatric weight management: data from the POWER Work Group. Pediatr Obes. 2021;16(1):e12701. https://doi.org/10.1111/ijpo.12701. Epub 2020 Sep 2. PMID: 32877010.

• Woo Baidal JA, Chang J, Hulse E, Turetsky R, Parkinson K, Rausch JC. Zooming toward a telehealth solution for vulnerable children with obesity during coronavirus disease 2019. Obesity (Silver Spring). 2020;28(7):1184–1186. https://doi.org/10.1002/oby.22860. Epub 2020 Jun 10. PMID: 32352650; PMCID: PMC7267304. Provides a review of utility of telemedicine for children with obesity which was highlighted during COVID.

Project ECHO. University of New Mexico. Accessed June 11, 2023. Available at https://hsc.unm.edu/echo/.

Lewiecki EM, Rochelle R. Project ECHO: telehealth to expand capacity to deliver best practice medical care. Rheum Dis Clin North Am. 2019;45(2):303–14. https://doi.org/10.1016/j.rdc.2019.01.003.

Article  PubMed  Google Scholar 

Novick MB, Wilson CT, Walker-Harding LR. Potential solutions for pediatric weight loss programs in the treatment of obesity in rural communities. Transl Behav Med. 2019;9(3):460–7. https://doi.org/10.1093/tbm/ibz030.

Article  PubMed  Google Scholar 

Updated telehealth and telemedicine timeline. Accessed June 11, 2023. https://www.umtrc.org/clientuploads/UMTRC%20Resource%20PDF/Updated_Telehealth_and_Telemedicine_Timeline.pdf.

•• Centers for Medicare and Medicaid Services. COVID-19 emergency declaration blanket waivers for health care providers. Updated October 13, 2023. Accessed June 11, 2023. Available at COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (cms.gov). Important reference for all providers using telehealth now and going forward after PHE.

Assistant Secretary for Planning and Evaluation. Medicare beneficiaries’ use of telehealth in 2020: trends by beneficiary characteristics and location. ASPE Office of Health Policy Research. Published December 2021. Accessed June 11, 2023. https://aspe.hhs.gov/sites/default/files/documents/a1d5d810fe3433e18b192be42dbf2351/medicare-telehealth-report.pdf.

Center for Connected Health Policy. Medicare telehealth/connected health waivers post-PHE. Published March 2, 2023. Accessed June 11, 2023 at https://www.cchpca.org/2023/03/MEDICARE-TELEHEALTH-POLICIES-POST-PHE-AT-A-GLANCE-FINAL-MAR-2023.pdf.

Drug Enforcement Association & Health and Human Services Department. Temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications. Published May 10, 2023. Accessed June 11, 2023 at https://www.federalregister.gov/documents/2023/05/10/2023-09936/temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled.

National Center for Interstate Compacts. Interstate licensure compacts. Accessed June 11, 2023. https://compacts.csg.org/covid-policy-responses/interstate-licensure-compacts/.

Fang ML, Walker M, Wong KLY, Sixsmith J, Remund L, Sixsmith A. Future of digital health and community care: exploring intended positive impacts and unintended negative consequences of COVID-19. Healthc Manage Forum. 2022;35(5):279–285. https://doi.org/10.1177/08404704221107362. Epub 2022 Jul 1. PMID: 35775162; PMCID: PMC9253718.

U.S. Department of Commerce National Telecommunications and Information Administration. Digital Equity Plan Guidance. https://broadbandusa.ntia.gov/sites/default/files/2022-09/Digital_Equity_Plan_Guidance.pdf. Accessed 11 June 2023.

Federal Communications Commission. Chairman Pai Archive: Bridging The Digital Divide For All Americans. Accessed June 11, 2023 at https://www.fcc.gov/ajit-pai-initiatives-archive.

Friedman AB, Gervasi S, Song H, Bond AM, Chen AT, Bergman A, David G, Bailey JM, Brooks R, Smith-McLallen A. Telemedicine catches on: changes in the utilization of telemedicine services during the COVID-19 pandemic. Am J Manag Care. 2022;28(1):e1–6. https://doi.org/10.37765/ajmc.2022.88771. PMID: 35049260.

Article  PubMed  Google Scholar 

North S. Expanding telehealth in adolescent care: moving beyond the COVID-19 pandemic. Pediatrics. 2023;151(Suppl 1):e2022057267J. https://doi.org/10.1542/peds.2022-057267J. PMID: 37010401.

Article  PubMed  Google Scholar 

Notario PM, Gentile E, Amidon M, Angst D, Lefaiver C, Webster K. Home-based telemedicine for children with medical complexity. Telemed J E Health. 2019 Nov;25(11):1123–1132. https://doi.org/10.1089/tmj.2018.0186. Epub 2019 Jan 30. PMID: 30628860; PMCID: PMC6842894

Moorman EL, Koskela-Staples NC, Mathai BB, Fedele DA, Janicke DM. Pediatric obesity treatment via telehealth: current evidence and future directions. Curr Obes Rep. 2021;10(3):371–84. https://doi.org/10.1007/s13679-021-00446-w. Epub 2021 Jul 24 PMID: 34302603.

Article  PubMed  Google Scholar 

Qiu LT, Sun GX, Li L, Zhang JD, Wang D, Fan BY. Effectiveness of multiple eHealth-delivered lifestyle strategies for preventing or intervening overweight/obesity among children and adolescents: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;5(13):999702. https://doi.org/10.3389/fendo.2022.999702. PMID: 36157474; PMCID: PMC9491112 .

Article  Google Scholar 

Srivastava G, Fox CK, Kelly AS, Jastreboff AM, Browne AF, Browne NT, Pratt JSA, Bolling C, Michalsky MP, Cook S, Lenders CM, Apovian CM. Clinical considerations regarding the use of obesity pharmacotherapy in adolescents with obesity. Obesity (Silver Spring). 2019;27(2):190–204. https://doi.org/10.1002/oby.22385. PMID: 30677262; PMCID: PMC6449849 .

Article  PubMed  Google Scholar 

• O'Hara VM, Johnston SV, Browne NT. The paediatric weight management office visit via telemedicine: pre- to post-COVID-19 pandemic. Pediatr Obes. 2020;15(8):e12694. https://doi.org/10.1111/ijpo.12694. Epub 2020 Jul 6. PMID: 32627434; PMCID: PMC7361154. Provides pre-pandemic to post-pandemic pediatric clinical care in a multidisciplinary setting experience along with important telehealth policies.

•• DeSilva S, Vaidya SS. The application of telemedicine to pediatric obesity: lessons from the past decade. Telemed J e-Health. 2021;27(2):159–66. https://doi.org/10.1089/tmj.2019.0314. Provides important 10-year review specifically for pediatric obesity using telemedicine.

Article  PubMed  Google Scholar 

Pecoraro P, Gallè F, Muscariello E, Di Mauro V, Daniele O, Forte S, Ricchiuti R, Liguori G, Valerio G. A telehealth intervention for ensuring continuity of care of pediatric obesity during the CoVid-19 lockdown in Italy. Nutr Metab Cardiovasc Dis. 2021;31(12):3502–3507. https://doi.org/10.1016/j.numecd.2021.09.026. Epub 2021 Oct 7. PMID: 34728130; PMCID: PMC8496959.

Calcaterra V, Verduci E, Vandoni M, Rossi V, Di Profio E, CarnevalePellino V, Tranfaglia V, Pascuzzi MC, Borsani B, Bosetti A, Zuccotti G. Telehealth: a useful tool for the management of nutrition and exercise programs in pediatric obesity in the COVID-19 era. Nutrients. 2021;13(11):3689. https://doi.org/10.3390/nu13113689. PMID: 34835945; PMCID: PMC8618189.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Kouvari M, Karipidou M, Tsiampalis T, et al. Digital health interventions for weight management in children and adolescents: systematic review and meta-analysis. J Med Internet Res. 2022;24(2):e30675. Published 2022 Feb 14. https://doi.org/10.2196/30675. Review of telehealth tools in hybrid model, need for more research for fully telehealth delivery.

Whitley A, Yahia N. Efficacy of clinic-based telehealth vs. face-to-face interventions for obesity treatment in children and adolescents in the United States and Canada: a systematic review. Child Obes. 2021;17(5):299–310. https://doi.org/10.1089/chi.2020.0347. Epub 2021 Apr 29. PMID: 33926238.

• Umano GR, Di Sessa A, Guarino S, Gaudino G, Marzuillo P, Miraglia Del Giudice E. Telemedicine in the COVID-19 era: taking care of children with obesity and diabetes mellitus. World J Diabetes. 2021;12(5):651–7. https://doi.org/10.4239/wjd.v12.i5.651. PMID: 33995852; PMCID: PMC8107973. Discusses impact of telemedicine on obesity and related complication of diabetes during covid.

Article  PubMed  PubMed Central  Google Scholar 

Rajkumar E, Gopi A, Joshi A, et al. Applications, benefits, and challenges of telehealth in India during COVID-19 pandemic and beyond: a systematic review. BMC Health Serv Res. 2023;23(1):7. Published 2023 Jan 4. https://doi.org/10.1186/s12913-022-08970-8

Aras M, Tchang BG, Crawford A, Bledsoe M, Fujioka K, Aronne LJ. Impact of telemedicine during the COVID-19 pandemic on patient attendance. Obesity (Silver Spring). 2021;29(7):1093–1094. https://doi.org/10.1002/oby.23180. Epub 2021 May 7. PMID: 33963678; PMCID: PMC8242458.

• Tchang BG, Morrison C, Kim JT, Ahmed F, Chan KM, Alonso LC, Aronne LJ, Shukla AP. Weight loss outcomes with telemedicine during COVID-19. Front Endocrinol (Lausanne). 2022;10(13):793290. https://doi.org/10.3389/fendo.2022.793290. PMID: 35360066; PMCID: PMC8960113. Provides data comparing various delivery models for obesity medicine care with clinical outcomes across telemedicine, hybrid, and face-to-face comparison. Highlights the need for pediatric data regarding similar study.

Article  Google Scholar 

•• Crawford A, Serhal E. Digital health equity and COVID-19: the innovation curve cannot reinforce the social gradient of health. J Med Internet Res. 2020;22(6):e19361. https://doi.org/10.2196/19361. PMID: 32452816; PMCID: PMC7268667. Provides important perspectives on equity as well as insights for potential solutions.

Article  PubMed  PubMed Central